Generic drug
A generic drug contains the same active ingredient as a previously marketed branded medicine. This article explains composition, regulation, history, uses, and how generics differ from brand-name drugs.
A generic drug is a medicinal product that contains the same active pharmaceutical ingredient(s) as a brand-name drug whose patent or exclusive rights have expired. Generics are intended to be therapeutically equivalent to the reference product so that they can be used interchangeably in ordinary clinical practice. They often appear under the drug's standard chemical name rather than a trademarked brand name.
Image gallery
2 Images
Composition and equivalence
Although a generic contains the same active substance, it may differ in inactive components such as binders, fillers, colorings, or coatings. Regulators require that a generic demonstrate bioequivalence to the reference product—meaning it delivers the same amount of active ingredient into the bloodstream at a similar rate—within defined limits. Manufacturers therefore must control formulation and manufacturing processes so the generic matches the efficacy and safety profile of the original.
Regulation and approval
National and regional medicines agencies review generic applications to ensure quality, safety, and therapeutic equivalence. The review typically focuses on analytical characterization, manufacturing quality, and bioequivalence studies rather than repeating large clinical trials. Many jurisdictions also use international nonproprietary names (INNs) to standardize nomenclature and reduce confusion between products produced by different manufacturers.
History and example
Modern generic markets grew from the interaction of patent law and pharmaceutical regulation. A commonly cited historical example is the pain-relieving medicine developed by the German firm Bayer, marketed under the trademark Aspirin. The active molecule, acetylsalicylic acid, eventually fell outside exclusive protection and became widely produced as a nonproprietary analgesic; this illustrates how a formerly branded drug can become available as generic product(s). The original product remains a trade name and is separate from generic versions containing the same active ingredient.
Uses, benefits, and economic impact
- Generics provide affordable alternatives to brand-name drugs, increasing access to essential medicines for patients and health systems.
- Because manufacturers do not usually repeat expensive clinical trials, generics are often cheaper to bring to market, reducing overall prescription costs.
- Wide availability of generics can stimulate competition, leading to additional price reductions and greater choice for prescribers and patients.
Distinctions and notable facts
- Trademark vs. active ingredient: A brand name is protected as a trademark, whereas the active chemical entity is not protected once patent and exclusivity periods end.
- Biosimilars: For complex biological medicines, near-equivalent products are called biosimilars and are subject to different regulatory standards than small-molecule generics.
- Interchangeability: Rules about substituting a brand-name drug with a generic vary by jurisdiction and may depend on proven bioequivalence and regulatory designation.
Generics play a central role in modern healthcare by maintaining therapeutic options while containing costs. Their availability depends on patent law, regulatory science, and manufacturing capability. For more general background on medicines and their development see further resources or regulatory guidance on the topic through authoritative texts and agencies.
Cost
Generics are usually cheaper than the drug of the initial supplier, since no research costs are incurred and the development costs for a generic drug are comparatively low. In a study conducted in September 2004, Stiftung Warentest found that the prices for generic drugs are sometimes only a third of the original drug. The Techniker Krankenkasse found even higher differences in 2014 in an inventory market report examining the costs and benefits of some drugs. In the price comparison between original preparations and generics of frequently prescribed rheumatism preparations, the original preparations were up to 20 times more expensive than comparable generics, medications against diabetes mellitus were up to a factor of 18. In order to save costs, the statutory health insurances, supported by the German Act on the Economic Efficiency of Pharmaceutical Care (Arzneimittelversorgungs-Wirtschaftlichkeitsgesetz, AVWG), started in 2007 to force pharmacies, with the help of discount contracts with pharmaceutical manufacturers, to hand out only particularly low-priced preparations against a health insurance prescription, irrespective of the doctor's prescription. In the case of existing rebate contracts, the pharmacist must therefore, in accordance with the health insurance fund, dispense another drug with the same active ingredient instead of the original drug prescribed by name (except for any existing aut idem regulation), which is very often a generic drug.
In order not to immediately lose the benefits achieved through pharmaceutical research to generic drug manufacturers, the products developed by the research-based drug manufacturers (organized in Germany in the Association of Research-Based Pharmaceutical Companies) are protected by patents. The patent protection means that the original preparations have no competition from generics in the first few years after market launch. However, it also hinders the use of cheap new drugs in developing countries.
Example
Acetylsalicylic acid-containing preparations are among the oldest and best-known generics. The active ingredient, originally developed by Bayer AG in Leverkusen and marketed in various drug formulations under the name Aspirin, is now a component of numerous generics such as ASS Ratiopharm.
Related articles
Author
AlegsaOnline.com Generic drug Leandro Alegsa
URL: https://en.alegsaonline.com/art/37973